These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10777704)

  • 41. Interaction effect between common polymorphisms in PPARgamma2 (Pro12Ala) and insulin receptor substrate 1 (Gly972Arg) on insulin sensitivity.
    Stumvoll M; Stefan N; Fritsche A; Madaus A; Tschritter O; Koch M; Machicao F; Häring H
    J Mol Med (Berl); 2002 Jan; 80(1):33-8. PubMed ID: 11862322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
    Caramori ML; Canani LH; Costa LA; Gross JL
    Diabetes; 2003 Dec; 52(12):3010-3. PubMed ID: 14633865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.
    Deeb SS; Fajas L; Nemoto M; Pihlajamäki J; Mykkänen L; Kuusisto J; Laakso M; Fujimoto W; Auwerx J
    Nat Genet; 1998 Nov; 20(3):284-7. PubMed ID: 9806549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.
    Meirhaeghe A; Fajas L; Helbecque N; Cottel D; Auwerx J; Deeb SS; Amouyel P
    Int J Obes Relat Metab Disord; 2000 Feb; 24(2):195-9. PubMed ID: 10702770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the peroxisome proliferator activated receptor gamma (PPARgamma) gene in HAIRAN syndrome with obesity.
    Globerman H; Zauberman Y; Makarov T; Beamer BA; Yen CJ; Shuldiner AR; Harel C; Karnieli E
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):479-85. PubMed ID: 10762291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.
    Ek J; Andersen G; Urhammer SA; Hansen L; Carstensen B; Borch-Johnsen K; Drivsholm T; Berglund L; Hansen T; Lithell H; Pedersen O
    Diabetologia; 2001 Sep; 44(9):1170-6. PubMed ID: 11596673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences.
    Douglas JA; Erdos MR; Watanabe RM; Braun A; Johnston CL; Oeth P; Mohlke KL; Valle TT; Ehnholm C; Buchanan TA; Bergman RN; Collins FS; Boehnke M; Tuomilehto J
    Diabetes; 2001 Apr; 50(4):886-90. PubMed ID: 11289057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PPARγ Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet.
    Garaulet M; Smith CE; Hernández-González T; Lee YC; Ordovás JM
    Mol Nutr Food Res; 2011 Dec; 55(12):1771-9. PubMed ID: 22102511
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The role of PPARgamma in the onset of type 2 diabetes].
    Hara K; Yamauchi T; Kubota N; Tobe K; Yamazaki T; Nagai R; Kadowaki T
    Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):317-24. PubMed ID: 14501167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A functional variant in the peroxisome proliferator-activated receptor gamma2 promoter is associated with predictors of obesity and type 2 diabetes in Pima Indians.
    Muller YL; Bogardus C; Beamer BA; Shuldiner AR; Baier LJ
    Diabetes; 2003 Jul; 52(7):1864-71. PubMed ID: 12829658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism.
    Stumvoll M; Häring H
    Diabetes; 2002 Aug; 51(8):2341-7. PubMed ID: 12145143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population.
    Malecki MT; Frey J; Klupa T; Skupien J; Walus M; Mlynarski W; Sieradzki J
    Diabetes Res Clin Pract; 2003 Nov; 62(2):105-11. PubMed ID: 14581147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The peroxisome proliferator activated receptorgamma2 (PPARgamma2) Pro12Ala variant: lack of association with type 2 diabetes in obese and non obese Tunisian patients.
    Zouari Bouassida K; Chouchane L; Jellouli K; Chérif S; Haddad S; Gabbouj S; Danguir J
    Diabetes Metab; 2005 Apr; 31(2):119-23. PubMed ID: 15959417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peroxisome proliferator activated receptor γ2 gene Pro12Ala gene polymorphism in type 2 diabetes and its relationship with diabetic nephropathy.
    Azab MM; Abdel-Azeez HA; Zanaty MF; El Alawi SM
    Clin Lab; 2014; 60(5):743-9. PubMed ID: 24839816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study.
    Kao WH; Coresh J; Shuldiner AR; Boerwinkle E; Bray MS; Brancati FL;
    Diabetes; 2003 Jun; 52(6):1568-72. PubMed ID: 12765972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
    Lindi VI; Uusitupa MI; Lindström J; Louheranta A; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Tuomilehto J;
    Diabetes; 2002 Aug; 51(8):2581-6. PubMed ID: 12145174
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.
    Oh EY; Min KM; Chung JH; Min YK; Lee MS; Kim KW; Lee MK
    J Clin Endocrinol Metab; 2000 May; 85(5):1801-4. PubMed ID: 10843155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The PPARgamma2 amino acid polymorphism Pro 12 Ala is prevalent in offspring of Type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects.
    Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Renn W; Häring HU
    Diabetologia; 1999 Jun; 42(6):758-62. PubMed ID: 10382597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not.
    Petrovic MG; Kunej T; Peterlin B; Dovc P; Petrovic D
    Diabetes Metab Res Rev; 2005; 21(5):470-4. PubMed ID: 15782399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of peroxisome proliferator-activated receptor (PPAR-γ) mRNA expression with Pro12Ala polymorphism in obesity.
    Berhouma R; Kouidhi S; Ammar M; Abid H; Ennafaa H; Benammar-Elgaaied A
    Biochem Genet; 2013 Apr; 51(3-4):256-63. PubMed ID: 23315125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.